TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biogen (Denmark) A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
259,564
|
307,510
|
259,685 |
| Earnings before taxes |
10,730
|
10,890
|
10,498 |
| Total assets |
198,578
|
160,344
|
243,158 |
| Current assets |
197,744
|
158,979
|
242,309 |
| Current liabilities |
59,265
|
29,522
|
120,645 |
| Equity capital |
138,796
|
130,457
|
122,019 |
| - share capital |
501
|
501
|
501 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
69.9%
|
81.4%
|
50.2% |
| Turnover per employee |
7,416
|
8,786
|
7,420 |
| Profit as a percentage of turnover |
4.1%
|
3.5%
|
4.0% |
| Return on assets (ROA) | |||
| Current ratio |
333.7%
|
538.5%
|
200.8% |
| Return on equity (ROE) |
7.7%
|
8.3%
|
8.6% |
| Change turnover |
-47,946
|
47,825
|
-43,711 |
| Change turnover % |
-16%
|
18%
|
-14% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.